Orkla India IPO Listing Today: Shares List at 2.75–3% Premium, Slip Up to 7% Intraday; GMP, Subscription & Analyst Views (Nov 6, 2025)

Orkla India IPO Listing Today: Shares List at 2.75–3% Premium, Slip Up to 7% Intraday; GMP, Subscription & Analyst Views (Nov 6, 2025)

MUMBAI | Thursday, November 6, 2025 — Packaged‑foods maker Orkla India made a muted stock‑market debut on Thursday, listing at a modest premium to the IPO price before giving up gains during the session. The stock opened at ₹750.10 on the NSE and ₹751.50 on the BSE vs an issue price of ₹730, but later slipped below the IPO price, underperforming grey‑market expectations that had signaled a stronger start. [1]


Listing day snapshot

  • Open: ₹750.10 (NSE), ₹751.50 (BSE); Issue price: ₹730. [2]
  • Intraday pressure: Within the first hour, the stock fell as much as ~7% from the listing price, hitting ₹697.15 on BSE and ₹702.85 on NSE, indicating a slide below the issue price. [3]
  • Expectations vs reality: Ahead of listing, the grey market premium (GMP) hovered around ₹66 (~9%), implying an indicative price near ₹796—well above the actual open. [4]
  • Market cap on listing: About ₹10,294.74 crore, per early‑session estimates. [5]
  • Listing mechanics: Shares admitted to trading on BSE (‘B’ Group) and NSE; stock participated in the Special Pre‑open Session (SPOS). [6]

IPO by the numbers

  • Offer size:₹1,667.54 crore, a 100% Offer for Sale (OFS) of 2.28 crore shares; no fresh issue proceeds to the company. Price band: ₹695–₹730. Lot size: 20 shares (min retail outlay ₹14,600 at upper band). [7]
  • Subscription strength:48.7× overall; QIB 117.63×, NII 54.42×, Retail 7.05–7.06×, Employees 15.12×. Bidding window ran Oct 29–31; allotment was Nov 3; listingNov 6. [8]
  • Intermediaries:BRLMs — ICICI Securities, Citigroup Global Markets India, J.P. Morgan India, Kotak Mahindra Capital; Registrar:KFin Technologies. [9]
  • Anchors: Raised about ₹499.6 crore from 30 anchor investors on Oct 28 by allotting 68.43 lakh shares at ₹730. [10]

Why the debut felt “lukewarm”

The listing premium of 2.75–3% was well below the ₹66 (~9%) GMP seen ahead of trade, signaling tempered secondary‑market appetite despite a blockbuster subscription book. As trading progressed, profit‑taking and broader market softness saw the stock reverse into the red, at one point down ~6–7% from the open. [11]


Company at a glance: brands & footprint

Orkla India—backed by Norway’s Orkla ASA—houses MTR Foods, Eastern Condiments and Rasoi Magic, spanning spices, masalas, ready‑to‑cook/ready‑to‑eat mixes, breakfast mixes and more. The business is organized into three units (MTR, Eastern, International) and exports to 40+ countries. Recent disclosures indicate double‑digit PAT margins (~10.7%) and steady topline growth. [12]


What analysts are saying

Early broker commentary framed the debut as “decent but below GMP hopes.” One view suggested partial profit‑booking by allottees with a disciplined stop‑loss, while another advised holding for the long term given Orkla India’s category leadership and the secular shift toward branded packaged foods. (Paraphrased from broker notes reported in the press.) [13]


Grey market vs. street: the gap explained

GMPs reflect unofficial sentiment and can soften into listing, especially when market mood is cautious. Today’s outcome underscores that oversubscription ≠ outsized listing pop; post‑listing price discovery still hinges on fundamentals, flows and day‑of sentiment. [14]


Key takeaways for investors (Nov 6, 2025)

  • Strong book, soft pop: Despite 48.7× bids, listing gains stayed low‑single‑digit. [15]
  • Quick reversal: The stock slid below the issue price intraday, at one point down ~7% from the open. [16]
  • Pure OFS:No fresh capital to the company; proceeds go to selling shareholders. [17]
  • Brand strength remains a pillar: A portfolio led by MTR and Eastern positions Orkla India to ride packaged‑food penetration trends. [18]

Context & chronology (all times IST, Nov 6)

  • 09:55–10:00 — Lists at ₹750.10 (NSE), ₹751.50 (BSE). [19]
  • ~10:20–11:10 — Shares trade lower; day’s low updates include ₹715 (early) and later ₹697.15/₹702.85 (BSE/NSE). [20]
  • Afternoon — Media characterizes debut as “lukewarm”/“muted” versus GMP‑implied pricing. [21]

The bottom line

Orkla India’s Dalal Street debut on November 6, 2025 mirrors a year in which subscription heat hasn’t always translated into splashy listing gains. With a pure OFS and brand‑rich portfolio, the stock now shifts from IPO mode to earnings execution—where margins, distribution expansion and product innovation will likely drive the narrative from here. [22]

Disclaimer: This article is for news and informational purposes only and is not investment advice. Markets are volatile; please consult a qualified advisor before making investment decisions.

References

1. www.business-standard.com, 2. www.business-standard.com, 3. www.financialexpress.com, 4. www.business-standard.com, 5. www.moneycontrol.com, 6. www.livemint.com, 7. www.business-standard.com, 8. www.business-standard.com, 9. groww.in, 10. www.business-standard.com, 11. www.business-standard.com, 12. groww.in, 13. www.business-standard.com, 14. www.business-standard.com, 15. www.business-standard.com, 16. www.financialexpress.com, 17. www.business-standard.com, 18. groww.in, 19. www.business-standard.com, 20. www.business-standard.com, 21. www.livemint.com, 22. www.business-standard.com

Stock Market Today

  • BigBear.ai Holdings (BBAI) Trades Above 12-Month Target; Analysts Weigh In
    November 6, 2025, 8:30 AM EST. BigBear.ai Holdings Inc (BBAI) recently traded at $5.23, topping the average 12-month target of $4.83 set by analysts. While the price sits above target, analysts span a wide range: one target at $3.50 and another at $6.00, with a standard deviation of $1.258, reflecting uneven views among the three contributing analysts. The move above the target raises questions about whether $4.83 is a stepping stone toward higher targets or a signal to take profits. Zacks coverage shows a mixed but constructive view: current ratings include two Strong Buy, two Hold, and no Sells, yielding an average Rating of 2.0 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell).
  • IREN Clears 12-Month Target, Trades at $76.41 as Target Range Runs From $24 to $142
    November 6, 2025, 8:28 AM EST. IREN Ltd (IREN) traded at $76.41 after overcoming the average 12-month target of $69.50. When a stock hits a target, analysts may downgrade on valuation or lift targets, depending on underlying fundamentals. Across Zacks' coverage there are 10 targets contributing to the average, with a low of $24 and a high of $142, producing a standard deviation of $32.613. The move above the average target fuels the "wisdom of crowds" thesis, prompting investors to decide whether $69.50 is a waypoint or the stock is now extended. Ratings show a tilt toward Strong Buys and Buys, with some Holds and a few Strong Sells less prevalent. Data sourced from Zacks via Quandl.
  • BHP Crosses Above Average Analyst Target of $67.33 as Shares Trade at $68.48
    November 6, 2025, 8:26 AM EST. Shares of BHP Group Ltd (BHP) moved to $68.48 and crossed above the average 12-month target of $67.33 cited by analysts. The move prompts reactions from analysts: potentially downgrades or renewed price targets, depending on underlying fundamentals. Zacks' coverage shows three targets feeding the average, with a low of $56 and a high of $87, and a standard deviation of $17.10. The piece highlights the 'wisdom of crowds' concept as investors weigh whether $67.33 is a stepping stone to higher valuations or a signal to trim positions. Current analyst ratings show 2 Strong Buys, 6 Holds, and no Sells, with an average rating of 2.5.
  • Qualys (QLYS) Clears 12-Month Analyst Target of $140.12; Shares Trade at $142.70
    November 6, 2025, 8:24 AM EST. Qualys, Inc. (QLYS) shares are trading at $142.70, topping the average 12-month analyst target of $140.12. When a stock hits an analyst target, the next move can be a downgrade or a raised target, depending on fundamental developments. The current picture shows 8 contributing targets in Zacks' coverage, with targets ranging from a low around $113 to a high of $175 and a standard deviation of about $22.71. The concept of a wisdom of crowds guides investors to weigh multiple views rather than relying on a single forecast. With QLYS above the average, investors may reassess whether $140.12 is a stepping stone to higher gains or a sign to take some chips off the table. Data from Zacks via Quandl.
  • Banco Santander Brasil Shares Edge Above 12-Month Target; Analysts Split on Next Move
    November 6, 2025, 8:22 AM EST. Banco Santander Brasil SA (BSBR) traded at $7.75, nudging above the average 12-month target of $7.72 set by analysts. With four targets in the Zacks coverage, the range spans from a low of $6.00 to a high of $10.00, and a standard deviation of $1.723. The move above the target sparks discussion whether this is a stepping stone to a higher price or a sign of overvaluation. The piece notes the wisdom of crowds behind the target, and highlights that investors should reassess fundamentals. The current analyst ratings show mostly Hold (3) with an average rating of 2.83 on a 1-5 scale, per Zacks via Quandl.
Investors Beware: 7 Stocks to Avoid on October 22, 2025 Amid Alarming Warnings
Previous Story

Michael Burry’s $1.1 Billion AI ‘Short’ Jolts Global Markets: Nvidia, Palantir Lead Tech Slide — What to Watch Today (Nov. 6, 2025)

Groww IPO Day 2: Fully Subscribed (1.47x); Retail 4.65x, GMP 11–15%; Nithin Kamath Says 20% of Applications Came via Zerodha — What Top Brokerages Recommend
Next Story

Groww IPO Day 2: Fully Subscribed (1.47x); Retail 4.65x, GMP 11–15%; Nithin Kamath Says 20% of Applications Came via Zerodha — What Top Brokerages Recommend

Go toTop